Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vi antigen is a capsular polysaccharide expressed on the surface of *Salmonella enterica* serovar Typhi, the causative agent of typhoid fever. This capsule is a key virulence factor that distinguishes S. Typhi from most other Salmonella serovars. It inhibits phagocytosis and reduces immune recognition, contributing to the bacterium's ability to cause infection. The purified Vi capsular polysaccharide is used in typhoid vaccines to induce protective antibodies.
Induction of anti-Vi antibodies that promote complement-mediated killing of Salmonella Typhi
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhi Capsular Polysaccharide (Vi Antigen) (Vi Antigen).